Antifouling coating with controllable and sustained silver release for long-term inhibition of infection and encrustation in urinary catheters

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 103, Issue 3, 2015, Pages 519-528

  Wang, Rong ^a   Neoh, Koon Gee ^a   Kang, En Tang ^a   Tambyah, Paul Anantharajah ^a   Chiong, Edmund ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

catheter; encrustation; infection; silver nanoparticles; surface modification

Indexed keywords

CATHETERS; COATINGS; NANOPARTICLES; SILICONES; SURFACE TREATMENT;

BACTERIAL INFECTIONS; ENCRUSTATION; INFECTION; NOSOCOMIAL INFECTION; PREDISPOSING FACTORS; SILVER NANOPARTICLES; SILVER NANOPARTICLES (AGNPS); URINARY TRACT INFECTIONS;

SILVER;

POLY(SULFOBETAINE METHACRYLATE COC ACRYLAMIDE); POLYACRYLAMIDE; POLYDOPAMINE; POLYMETHACRYLIC ACID DERIVATIVE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; ACRYLIC ACID RESIN; ANTIINFECTIVE AGENT; BETAINE; BIOMATERIAL; DELAYED RELEASE FORMULATION; INDOLE DERIVATIVE; NANOPARTICLE; POLY(SULFOBETAINE METHACRYLATE-CO-ACRYLAMIDE); POLYMER; SILICONE DERIVATIVE; SILVER DERIVATIVE; SILVER NITRATE; SOLUTION AND SOLUBILITY;

ARTICLE; BACTERIOSTASIS; BACTERIUM ADHERENCE; BIOFILM; CATHETER ENCRUSTATION; CATHETER INFECTION; FOLEY BALLOON CATHETER; HUMAN; MATERIAL COATING; NONHUMAN; PROTEUS MIRABILIS; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; URINARY CATHETER; 3T3 CELL LINE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BLADDER; BLADDER CATHETERIZATION; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; FRICTION; IN VITRO STUDY; MATERIALS TESTING; MOUSE; PHYSIOLOGY; PIG; SOLUBILITY; SOLUTION AND SOLUBILITY; TENSILE STRENGTH; TIME; URINARY TRACT INFECTIONS;

3T3 CELLS; ACRYLIC RESINS; ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL ADHESION; BETAINE; BIOFILMS; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; FRICTION; IN VITRO TECHNIQUES; INDOLES; MATERIALS TESTING; MICE; NANOPARTICLES; POLYMERS; PROTEUS MIRABILIS; SILICONES; SILVER COMPOUNDS; SILVER NITRATE; SOLUBILITY; SOLUTIONS; SWINE; TENSILE STRENGTH; TIME FACTORS; URINARY BLADDER; URINARY CATHETERIZATION; URINARY CATHETERS; URINARY TRACT INFECTIONS;

EID: 84925613303     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33230     Document Type: Article

References (32)

1. Saint S, Chenoweth CE,. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin N Am 2003; 17: 411-432.
2. Paick SH, Park HK, Oh SJ, Kim HH,. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent. Urology 2003; 62: 214-217.
3. Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME,. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008; 21: 26-59.
4. Kehinde EO, Rotimi VO, Al-Hunayan A, Abdul-Halim H, Boland F, Al-Awadi KA,. Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol 2004; 18: 891-896.
5. Stickler DJ, Feneley RCL,. The encrustation and blockage of long-term indwelling bladder catheters: A way forward in prevention and control. Spinal Cord 2010; 48: 784-790.
6. Jacobsen SM, Shirtliff ME,. Proteus mirabilis biofilms and catheter-associated urinary infections. Virulence 2011; 2: 460-465.
7. Bryan CS, Reynolds KL,. Hospital-acquired bacteremic urinary tract infection: Epidemiology and outcome. J Urol 1984; 132: 494-498.
8. Getliffe KA,. The characteristics and management of patients with recurrent blockage of long-term urinary catheters. J Adv Nurs 1994; 20: 140-149.
9. Kawahara T, Ito H, Terao H, Yoshida M, Matsuzaki J,. Ureteral stent encrustation, incrustation, and coloring: Morbidity related to indwelling times. J Endourol 2012; 26: 178-182.
10. Denstedt JD, Cadieux PA,. Eliminating biofilm from ureteral stents: The holy grail. Curr Opin Urol 2009; 19: 205-210.
11. Desai DG, Liao KS, Cevallos ME, Trautner BW,. Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence. J Urol 2010; 184: 2565-2571.
12. Cadieux PA, Chew BH, Knudsen BE, DeJong K, Rowe E, Reid G, Denstedt JD,. Triclosan loaded ureteral stents decrease Proteus mirabilis 296 infection in a rabbit urinary tract infection model. J Urol 2006; 175: 2331-2335.
13. Mendez-Probst CE, Goneau LW, MacDonald KW, Nott L, Seney S, Elwood CN, Lange D, Chew BH, Denstedt JD, Cadieux PA,. The use of triclosan eluting stents effectively reduces ureteral stent symptoms: A prospective randomized trial. BJU Int 2012; 110: 749-754.
14. Chung PY, Toh YS,. Anti-biofilm agents: Recent breakthrough against multi-drug resistant Staphylococcus aureus. Pathog Dis 2014; 70: 231-239.
15. Chernousova S, Epple M,. Silver as antibacterial agent: Ion, nanoparticle, and metal. Angew Chem Int Ed 2013; 52: 1636-1653.
16. Multanen M, Tammela TLJ, Laurila M, Seppälä J, Välimaa T, Törmälä P, Talja M,. Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-L-lactic acid stents in rabbit urethra. Urol Res 2002; 30: 227-232.
17. Chakravarti A, Gangodawila S, Long MJ, Morris NS, Blacklock ARE, Stickler DJ,. An electrified catheter to resist encrustation by Proteus mirabilis biofilm. J Urol 2005; 174: 1129-1132.
18. Agarwala M, Barman T, Gogoi D, Choudhury B, Pal AR, Yadav RNS,. Highly effective antibiofilm coating of silver-polymer nanocomposite on polymeric medical devices deposited by one step plasma process. J Biomed Mater Res Part B 2014; doi: 10.1002/jbm.b.33106.
19. Broomfield RJ, Morgan SD, Khan A, Stickler DJ,. Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: A simple method of control. J Med Microbiol 2009; 58: 1367-1375.
20. Morgan SD, Rigby D, Stickler DJ,. A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters. Urol Res 2009; 37: 89-93.
21. Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, Glazener C, Boachie C, Burr J, Norrie J, Vale L, Grant A, N'Dow J,. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catherisation in hospital: A multicentre randomised controlled trial. Lancet 2012; 380: 1927-1935.
22. Lee H, Dellatore SM, Miller WM, Messersmith PB,. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007; 318: 426-430.
23. Lynge ME, van der Westen R, Postma A, Städler B,. Polydopamine-a nature-inspired polymer coating for biomedical science. Nanoscale 2011; 3: 4916-4928.
24. Ma YR, Niu HY, Zhang XL, Cai YQ,. Colorimetric detection of copper ions in tap water during the synthesis of silver/dopamine nanoparticles. Chem Commun 2011; 47: 12643-12645.
25. Sileika TS, Kim HD, Maniak P, Messersmith PB,. Antibacterial performance of polydopamine-modified polymer surfaces containing passive and active components. ACS Appl Mater Interf 2011; 3: 4602-4610.
26. Cheng G, Zhang Z, Chen S, Bryers JD, Jiang S,. Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials 2007; 28: 4192-4199.
27. Chen SL, Hung CS, Xu J, Reigstad CS, Magrini V, Sabo A, Blasiar D, Bieri T, Meyer RR, Ozersky P, Armstrong JR, Fulton RS, Latreille JP, Spieth J, Hooton TM, Mardis ER, Hultgren SJ, Gordon JI,. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: A comparative genomics approach. Proc Natl Acad Sci USA 2006; 103: 5977-5982.
28. Wang R, Neoh KG, Shi Z, Kang ET, Tambyah PA, Chiong E,. Inhibition of Escherichia coli and Proteus mirabilis adhesion and biofilm formation on medical grade silicone surface. Biotechnol Bioeng 2012; 109: 336-345.
29. International Organization for Standardization (ISO). Biological evaluation of medical devices-Part 5: Tests for in vitro cytotoxicity. ISO 10993-5:2009(E). International Organization for Standardization (ISO); 2009. pp. 1-34.
30. Levard C, Mitra S, Yang T, Jew AD, Badireddy AR, Lowry GV, Brown GEJ,. Effect of chloride on the dissolution rate of silver nanoparticles and toxicity to E. coli. Environ Sci Technol 2013; 47: 5738-5745.
31. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA, the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for prevention of catheter-associated urinary tract infections 2009. Centers for Disease Control and Prevention, US Department of Health and Human Services; 2009. pp. 1-67.
32. Li M, Neoh KG, Xu LQ, Wang R, Kang ET, Lau T, Olszyna DP, Chiong E,. Surface modification of silicone for biomecial applicatioins requiring long-term antibacterial, antifouling and hemocompatible properties. Langmuir 2012; 28: 16408-16022.